Tom Edlind Email and Phone Number
I have 30+ years hands-on research experience in medical microbiology, molecular biology, and genetics; 80+ publications on subjects ranging from bacteria to protozoa to fungi with emphases on antimicrobials, evolution, and technology development; and extensive experience writing, editing, reviewing, and editing grant applications and manuscripts.
-
Bingya CompanySan Francisco, Ca, Us
-
FounderMicrobitype Llc Jan 2014 - PresentRecent years have seen an exponential increase in the availability of genome sequences for many important microbes, particularly bacteria responsible for foodborne and healthcare-associated infections. MicrobiType was founded with the goal of applying these genome sequences to the development of improved strain typing methods. Typing is critical to outbreak detection and investigation, but currently used methods have serious limitations. MicrobiType's polymorphic locus sequence typing (PLST, patent pending) services provide a viable outsourcing option for food industries, healthcare facilities, public health labs, pharma, and researchers. -
ConsultantMicrobiology Consulting Sep 2012 - PresentAnalysis of microbial genome sequences using optimized bench and bioinformatic approaches, with the dual goals of improving strain identification and predicting antimicrobial resistance. These technologies will be of value to the pathogen surveillance and outbreak detection/investigation efforts of healthcare facilities, food and pharma industries, and public health labs.
-
EditorAsm Journal Antimicrobial Agents And Chemotherapy Jan 2006 - Dec 2012AAC is the leading journal in its field. I had primary responsiblity for editing manuscripts relating to antifungal and antiparastic agents, working closely with authors and reviewers.
-
ProfessorMed Col Pennsylvania/Drexel Med Aug 1984 - Aug 2012- Published 80 research papers (see below for representative, well cited examples) and 5 book chapters- Invited speaker at 9 international conferences- Awarded 12 research grants from NIH, foundations, and pharma- Co-developer of ribotyping, PCR-ribotyping, and technologies for yeast molecular genetics- Used tubulin phylogenetics to identify Pneumocystis and microsporidia as primitive fungi and Giardia and Trichomonas as early branching eukaryotes- Characterized molecular mechanisms of resistance to antifungal azoles, echinocandins, and flucytosine- Awarded two patents for novel antifungal and antiprotozoal therapies- Mentored 14 graduate and postdoctoral trainees and 75 research interns- Developed and directed 5 graduate courses in microbiology, molecular biology, and genetics
-
ReviewerBiomedical Research Funding Agencies 1988 - 2012Invited grant reviewer for NIH, USDA, Wellcome Trust, WHO, Australian Research Council, Medical Research Council of Canada, German-Israeli Foundation for Scientific Research, Austrian Science Fund, Science Foundation Ireland (2005), Swiss National Science Foundation, Human Frontier Science Program, etc.
Tom Edlind Skills
Tom Edlind Education Details
-
Suny Upstate MedMicrobiology -
Connecticut CollegeChemistry
Frequently Asked Questions about Tom Edlind
What company does Tom Edlind work for?
Tom Edlind works for Bingya Company
What is Tom Edlind's role at the current company?
Tom Edlind's current role is Founder, MicrobiType LLC.
What schools did Tom Edlind attend?
Tom Edlind attended Suny Upstate Med, Connecticut College.
What skills is Tom Edlind known for?
Tom Edlind has skills like Microbiology, Food Safety, Infectious Diseases, Molecular Epidemiology, Nosocomial Infection, Public Health Surveillance, Antimicrobial Resistance, Pathogens, Genotyping, Microbial Source Tracking, Dna Sequencing.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial